BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 7718417)

  • 21. Anti-neutrophil cytoplasmic antibodies: a new class of autoantibodies in glomerulonephritis, vasculitis and other inflammatory disorders.
    Tervaert JW; Stegeman CA; Brouwer E; Mulder AH; Limburg PC; Kallenberg CG
    Neth J Med; 1994 Dec; 45(6):262-72. PubMed ID: 7838242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antineutrophil cytoplasmic autoantibodies, autoantigens, and systemic vasculitis.
    Gross WL; Csernok E; Helmchen U
    APMIS; 1995 Feb; 103(2):81-97. PubMed ID: 7748541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis.
    Choi HK; Merkel PA; Tervaert JW; Black RM; McCluskey RT; Niles JL
    Arthritis Rheum; 1999 Feb; 42(2):384-8. PubMed ID: 10025935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Usefulness of anti-neutrophil cytoplasmic antibodies, anti-proteinase 3 and anti-myeloperoxidase in management of small vessel vasculitis].
    Ara J; Mirapeix E; Rodríguez R; Pascual J; Alvarez L; Darnell A
    Med Clin (Barc); 1998 Oct; 111(14):536-8. PubMed ID: 9859079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antineutrophil cytoplasmic antibodies in the classification of vasculitis.
    Niles JL
    Annu Rev Med; 1996; 47():303-13. PubMed ID: 8712783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of Wegener's granulomatosis.
    Gross WL; Trabandt A; Csernok E
    Ann Med Interne (Paris); 1998 Sep; 149(5):280-6. PubMed ID: 9791561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wegener's granulomatosis--autoimmunity to neutrophil proteinase 3.
    Watorek E; Boratyńska M; Klinger M
    Arch Immunol Ther Exp (Warsz); 2003; 51(3):157-67. PubMed ID: 12894870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B cell epitope specificity in ANCA-associated vasculitis: does it matter?
    van der Geld YM; Stegeman CA; Kallenberg CG
    Clin Exp Immunol; 2004 Sep; 137(3):451-9. PubMed ID: 15320893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele.
    Griffith ME; Lovegrove JU; Gaskin G; Whitehouse DB; Pusey CD
    Nephrol Dial Transplant; 1996 Mar; 11(3):438-43. PubMed ID: 8671812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What you should know about PR3-ANCA. Evidence for the role of T cells in the pathogenesis of systemic vasculitis.
    Clayton AR; Savage CO
    Arthritis Res; 2000; 2(4):260-2. PubMed ID: 11094438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
    Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
    Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What do antineutrophil cytoplasmic antibodies (ANCA) tell us?
    Savige J; Pollock W; Trevisin M
    Best Pract Res Clin Rheumatol; 2005 Apr; 19(2):263-76. PubMed ID: 15857795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa.
    Porges AJ; Redecha PB; Kimberly WT; Csernok E; Gross WL; Kimberly RP
    J Immunol; 1994 Aug; 153(3):1271-80. PubMed ID: 8027554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New aspects of antineutrophil cytoplasmic antibody (ANCA) diagnosis in vasculitis].
    Csernok E; Reichel P; Gross WL
    Z Rheumatol; 2002 Aug; 61(4):367-77. PubMed ID: 12426842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiproteinase 3- and antimyeloperoxidase-associated vasculitis.
    Franssen CF; Stegeman CA; Kallenberg CG; Gans RO; De Jong PE; Hoorntje SJ; Tervaert JW
    Kidney Int; 2000 Jun; 57(6):2195-206. PubMed ID: 10844589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antineutrophil cytoplasmic antibodies: major autoantigens, pathophysiology, and disease associations.
    Schultz DR; Tozman EC
    Semin Arthritis Rheum; 1995 Dec; 25(3):143-59. PubMed ID: 8650585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of proteinase 3 with its associated partners: implications in the pathogenesis of Wegener's granulomatosis.
    Witko-Sarsat V; Reuter N; Mouthon L
    Curr Opin Rheumatol; 2010 Jan; 22(1):1-7. PubMed ID: 19881350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA genes in ANCA-associated vasculitides.
    Griffith ME; Pusey CD
    Exp Clin Immunogenet; 1997; 14(3):196-205. PubMed ID: 9493788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neurological involvement in Wegener's granulomatosis].
    Asakura K; Muto T
    Brain Nerve; 2013 Nov; 65(11):1311-7. PubMed ID: 24200609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and pathological manifestations of patients with antineutrophil cytoplasmic autoantibodies directed against proteinase 3 or myeloperoxidase.
    Zhang X; Dong Y; Zeng X; Li Y; Tang F
    Chin Med Sci J; 2002 Mar; 17(1):32-5. PubMed ID: 12894882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.